Back to Search
Start Over
TCT-662 Patients Who Do Not Receive Drug-Eluting Stent for In-Stent Restenosis: Characteristics and Outcomes
- Source :
- Journal of the American College of Cardiology. 74:B650
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- Drug-eluting stents (DES) remain the most widely used treatment for in-stent restenosis (ISR). In this analysis we sought to determine the proportion, characteristics, and outcomes of patients who do or do not receive DES for ISR. We included all patients undergoing percutaneous coronary
Details
- ISSN :
- 07351097
- Volume :
- 74
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........694079d919704b962048d11a97506121